RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
1-Year Return 25.98%
This Quarter Return
-17.44%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.12B
AUM Growth
-$643M
Cap. Flow
-$85.3M
Cap. Flow %
-4.03%
Top 10 Hldgs %
32.59%
Holding
150
New
6
Increased
39
Reduced
39
Closed
16

Top Buys

1
WCG
Wellcare Health Plans, Inc.
WCG
$36.4M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$19.4M
3
SGEN
Seagen Inc. Common Stock
SGEN
$11.5M
4
NBIX icon
Neurocrine Biosciences
NBIX
$10.3M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
$9.78M

Top Sells

1
ABBV icon
AbbVie
ABBV
$30.7M
2
MOH icon
Molina Healthcare
MOH
$23.6M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
$17.3M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
$15.1M
5
ELAN icon
Elanco Animal Health
ELAN
$13.1M

Sector Composition

1 Healthcare 88.36%
2 Consumer Staples 0.36%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ABBV icon
126
AbbVie
ABBV
$375B
– –
-325,000
Closed -$30.7M
ENTA icon
127
Enanta Pharmaceuticals
ENTA
$189M
– –
-92,500
Closed -$7.91M
MCRB icon
128
Seres Therapeutics
MCRB
$169M
– –
-11,000
Closed -$1.67M
SCYX icon
129
SCYNEXIS
SCYX
$37.3M
– –
-82,000
Closed -$984K
ADVM icon
130
Adverum Biotechnologies
ADVM
$73.9M
– –
-90,000
Closed -$5.45M
CDTX icon
131
Cidara Therapeutics
CDTX
$1.6B
– –
-15,000
Closed -$1.32M
CLSD icon
132
Clearside Biomedical
CLSD
$27.2M
– –
-975,000
Closed -$6M
ELAN icon
133
Elanco Animal Health
ELAN
$9.16B
– –
-375,000
Closed -$13.1M
VKTX icon
134
Viking Therapeutics
VKTX
$3.03B
– –
-200,000
Closed -$3.48M
VYNE icon
135
VYNE Therapeutics
VYNE
$7.62M
– –
-4,583
Closed -$3.25M
ITCI
136
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-187,500
Closed -$4.07M
ONCT
137
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
– –
0
– –
ARNA
138
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-375,000
Closed -$17.3M
UROV
139
DELISTED
Urovant Sciences Ltd.
UROV
– –
-100,000
Closed -$1.2M
AGN
140
DELISTED
Allergan plc
AGN
– –
-17,665
Closed -$3.37M
ECYT
141
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-850,000
Closed -$15.1M
2 3 4 5
6